Theravance Biopharma (TBPH) Profit After Tax Growth (3y) (2016 - 2026)
Theravance Biopharma (TBPH) Profit After Tax Growth (3y) (2016 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
PAT Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
762,369.55 Bn |
762,369.51 Bn |
- |
- |
| 2 |
Belite Bio |
55,096.00 Bn |
55,096.00 Bn |
- |
84.25% |
| 3 |
Quantum Biopharma |
17,755.80 Bn |
17,755.79 Bn |
- |
33.21% |
| 4 |
Legend Biotech |
3,486.00 Bn |
3,485.71 Bn |
242.10 Mn |
30.60% |
| 5 |
Akari Therapeutics |
1,737.42 Bn |
1,737.41 Bn |
- |
-154.28% |
| 6 |
Evaxion A |
1,551.28 Bn |
1,551.26 Bn |
- |
16.53% |
| 7 |
Psyence Biomedical |
227.32 Bn |
227.31 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
110.84 Bn |
103.59 Bn |
2.59 Bn |
13.80% |
| 9 |
Abivax |
91.71 Bn |
91.71 Bn |
- |
- |
| 10 |
Theravance Biopharma |
839.69 Mn |
445.03 Mn |
- |
39.33% |
| Date | Value |
|---|
| Mar 31, 2026 |
39.33% |
| Dec 31, 2025 |
84.50% |
| Sep 30, 2025 |
32.87% |
| Jun 30, 2025 |
105.63% |
| Mar 31, 2025 |
31.11% |
| Dec 31, 2024 |
35.48% |
| Sep 30, 2024 |
38.99% |
| Jun 30, 2024 |
31.93% |
| Mar 31, 2024 |
48.72% |
| Dec 31, 2023 |
47.39% |
| Sep 30, 2023 |
50.47% |
| Jun 30, 2023 |
37.11% |
| Mar 31, 2023 |
35.69% |
| Dec 31, 2022 |
39.88% |
| Sep 30, 2022 |
43.64% |
| Jun 30, 2022 |
40.98% |
| Mar 31, 2022 |
16.97% |
| Dec 31, 2021 |
-4.83% |
| Sep 30, 2021 |
2.02% |
| Jun 30, 2021 |
-8.69% |
